/Companies

Qubigen

1 known investors

Find your way into Qubigen

Sign up to see every warm intro you have to Qubigen

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Qubigen team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Qubigen provides end-to-end AI drug design as a service, using a global federated AI system and computational workflows to generate and optimize novel drug candidates for specific protein targets. Its federated approach draws insights from clients' protected, sensitive data without moving or viewing it, serving pharmaceutical and drug discovery researchers.

Investors · 1

Frequently asked questions

What does Qubigen do?
Qubigen provides end-to-end AI drug design as a service, using a global federated AI system and computational workflows to generate and optimize novel drug candidates for specific protein targets. Its federated approach draws insights from clients' protected, sensitive data without moving or viewing it, serving pharmaceutical and drug discovery researchers.
Who are Qubigen's investors?
Qubigen's investors include 3Lines Venture Capital.